Reference range(s)
The reference ranges listed below are valid on this date of November 29, 2025.
| Component | Age | Male Norm | Male Critical Low | Male Critical High | Female Norm | Female Critical High | Female Critical Low | Units | Add'l info |
|---|---|---|---|---|---|---|---|---|---|
| Encephalopathy, Interpretation, S | ALL | See report. | |||||||
| AMPA-R Ab CBA, S | ALL | See report. | |||||||
| Amphiphysin Ab, S | ALL | See report. | |||||||
| AGNA-1, S | ALL | See report. | |||||||
| ANNA-1, S | ALL | See report. | |||||||
| ANNA-2, S | ALL | See report. | |||||||
| ANNA-3, S | ALL | See report. | |||||||
| CASPR2-IgG CBA, S | ALL | See report. | |||||||
| GABA-B-R Ab CBA, S | ALL | See report. | |||||||
| GAD65 Ab Assay, S | ALL | See report. | |||||||
| GFAP IFA, S | ALL | See report. | |||||||
| LGI1-IgG CBA, S | ALL | See report. | |||||||
| mGluR1 Ab IFA, S | ALL | See report. | |||||||
| NIF IFA, S | ALL | See report. | |||||||
| NMDA-R Ab CBA, S | ALL | See report. | |||||||
| PCA-1, S | ALL | See report. | |||||||
| PCA-2, S | ALL | See report. | |||||||
| PCA-Tr, S | ALL | See report. | |||||||
| CRMP-5-IgG, S | ALL | See report. | |||||||
| IFA Notes | ALL | See report. | |||||||
| Neurochondrin IFA, S | ALL | See report. | |||||||
| Septin-7 IFA, S | ALL | See report. | |||||||
| DPPX Ab CBA, S | ALL | See report. | |||||||
| IgLON5 CBA, S | ALL | See report. | |||||||
| PDE10A Ab IFA, S | ALL | See report. | |||||||
| TRIM46 Ab IFA, S | ALL | See report. |